The system, which has received CE Mark approval in Europe, adds to an increasingly crowded field of PFA technologies.
Nordic Pharma plans to announce commercialization details in the near future for the dry eye disease treatment ...
Zimmer Biomet (NYSE:ZBH) announced Tuesday that the EU regulators granted CE Mark certification for the company’s RibFix ...
Zimmer Biomet (NYSE: ZBH) + Zimmer Biomet Holdings, Inc. $112.503 0.58% Open 111.5 Day High 113.6 52 Week High 133.6 52 Week ...
Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities ...
Thursday announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation (AFib).
Abbott Laboratories ( ABT 4.02%) stock was in fine health on the second-to-last trading day of the week, thanks to news from Europe. Investors greeted this positively, rewarding the company with a ...
Alcon (ALC) announced that Vivity, the most widely implanted extended depth of focus intraocular lens, is now available on Alcon’s most ...
(PRNewsfoto/Zimmer Biomet Holdings, Inc.) "Following the success of RibFix Advantage Fixation System in the United States and other markets, we are excited to introduce it in CE Mark markets and ...